The use of opioids nine months after surgery for Crohn's disease – a nationwide cohort study

Documenti analoghi

• Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series
  di: Rahul S. Dalal, et al.
  Pubblicazione: (2025)
• The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study
  di: Bente Mertz Nørgård, et al.
  Pubblicazione: (2025)
• Editorial: Surgery to reduce opioid use in Crohn's disease: Does a classic solution address a newer problem?
  di: Tarun Chhibba
  Pubblicazione: (2024)
• Editorial: Upadacitinib in Perianal Crohn's Disease
  di: Manjeet Kumar Goyal, et al.
  Pubblicazione: (2026)
• Treatment of inflammatory bowel disease with steroid‐sparing medications is age‐dependent – Results from a Danish nationwide cohort study, 2000–2018
  di: Rie Louise Møller Nordestgaard, et al.
  Pubblicazione: (2024)